Increased basic knowledge of the mechanisms of glioma development could also help discover novel therapeutic targets, in analogy with how PARP inhibitors were discovered as a therapy in BRCA1 positive breast cancer patients [13]. Here, BRCA1 is linked to breast carcinoma.